CN1244417A - Leukoderma curing medicine - Google Patents

Leukoderma curing medicine Download PDF

Info

Publication number
CN1244417A
CN1244417A CN 99110581 CN99110581A CN1244417A CN 1244417 A CN1244417 A CN 1244417A CN 99110581 CN99110581 CN 99110581 CN 99110581 A CN99110581 A CN 99110581A CN 1244417 A CN1244417 A CN 1244417A
Authority
CN
China
Prior art keywords
medicine
leukoderma
liang
present
money
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 99110581
Other languages
Chinese (zh)
Inventor
刘林生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 99110581 priority Critical patent/CN1244417A/en
Publication of CN1244417A publication Critical patent/CN1244417A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a medicine specially for treating leukoderma. The present invention cure leukoderma radically through dispelling wind evil, sterilization, and regulating the blood. The medicine is low in cost, and simple in preparation process and has no side effect.

Description

Effect a radical cure leukodermic medicine
The present invention relates to a kind of medicine of special curing vitiligo
At present the leukodermic medicine majority of treatment exists that cure rate is low can not to dig up the roots, and has part that the high shortcoming of side effect cost is arranged:
Purpose of the present invention provides that a kind of cost is low, curative effect is fast, can effect a radical cure leukodermic medicine.
The present invention adopts the principle of air-out, sterilization and blood to make.
Owing to adopt such scheme that the present invention is reached with lower cost, can effect a radical cure leukodermic curative effect.
Below be the detailed prescription of this medicine: 2 liang of Lithargyrums, 2 liang of Fructus Cnidiis, Calomelas 1 money, sulfur 1 money, bright white eggplant 500 grams.Manufacture method: with the bright eggplant section of all powder porphyrizes
Usage: dip in powder with the eggplant sheet and apply the affected part, every day secondary

Claims (1)

1. the medicine of a special curing vitiligo, it comprises 2 liang of Lithargyrums, 2 liang of Fructus Cnidiis, Calomelas 1 money, bright white eggplant lower limb and Fructus Cucumidis sativi, it is characterized in that mainly containing in the medicine 2 liang of Lithargyrums, 2 liang of Fructus Cnidiis, Calomelas 1 money, sulfur 1 money
CN 99110581 1999-07-21 1999-07-21 Leukoderma curing medicine Pending CN1244417A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 99110581 CN1244417A (en) 1999-07-21 1999-07-21 Leukoderma curing medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 99110581 CN1244417A (en) 1999-07-21 1999-07-21 Leukoderma curing medicine

Publications (1)

Publication Number Publication Date
CN1244417A true CN1244417A (en) 2000-02-16

Family

ID=5274611

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 99110581 Pending CN1244417A (en) 1999-07-21 1999-07-21 Leukoderma curing medicine

Country Status (1)

Country Link
CN (1) CN1244417A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101342269B (en) * 2008-08-28 2010-10-06 许建成 Chinese traditional medicine preparation for vitligo
CN102908492A (en) * 2012-10-24 2013-02-06 尹甲仑 Traditional Chinese medicine composition for treating vitiligo and preparation method of traditional Chinese medicine composition
CN111494519A (en) * 2020-06-12 2020-08-07 张奇虎 A topical Chinese medicinal composition for treating vitiligo, and its preparation method
CN114767727A (en) * 2022-04-12 2022-07-22 重庆三峡学院 Method for treating leucoderma by using Chinese herbal medicines

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101342269B (en) * 2008-08-28 2010-10-06 许建成 Chinese traditional medicine preparation for vitligo
CN102908492A (en) * 2012-10-24 2013-02-06 尹甲仑 Traditional Chinese medicine composition for treating vitiligo and preparation method of traditional Chinese medicine composition
CN102908492B (en) * 2012-10-24 2014-02-12 尹甲仑 Traditional Chinese medicine composition for treating vitiligo and preparation method of traditional Chinese medicine composition
CN111494519A (en) * 2020-06-12 2020-08-07 张奇虎 A topical Chinese medicinal composition for treating vitiligo, and its preparation method
CN114767727A (en) * 2022-04-12 2022-07-22 重庆三峡学院 Method for treating leucoderma by using Chinese herbal medicines

Similar Documents

Publication Publication Date Title
NZ521737A (en) The surface treatment of implants and prosthesis in titanium and other materials
CA2411095A1 (en) Transcutaneous prosthesis
BR0015110A (en) Methods of treating cell proliferative diseases, of treating a disorder associated with ksp kinesin activity, of ksp kinesin inhibition, of kps kinesin modulators and of screening compounds that bind ksp kinesin, and compounds
RU2003101908A (en) Transdermal prosthesis
IL187513A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
ID27414A (en) NON-PEPTIDIL OBSTACLES FROM VLA-4 RELIEF BINDERS USING THE BENEFITS IN TREATMENT OF INFLAMATION, AUTOIMUN AND BREATHING DISEASES
WO2002007749A3 (en) Device providing regulated growth factor delivery for the regeneration of peripheral nerves
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
CN1244417A (en) Leukoderma curing medicine
WO2004075849A3 (en) Method and composition for treating hypopigmentation of the hair and skin
WO2000057867A3 (en) Improved cancer treatment with temozolomide
WO2008027288A3 (en) Treatment for craniosynostosis by growth factor delivery
WO2004045554A3 (en) Cytomodulating peptides for treating interstitial cystitis
IL159770A0 (en) Calcium salts with cytotoxic activity
MD1140B1 (en) Remedy possessing a regenerative and cytoprotective activity
CA2469779A1 (en) Method for the treatment of bone disorders
CN1085088C (en) Medicine for treating psoriasis
CN1213547A (en) Ointment for treating skin burn and scald and ulcer
GB2369054A (en) Treatment of IL deficiencies
WO2003024486A1 (en) Remedies for bone loss
GEU1997133Y (en) Method for Treatment of Chronic Rinites and Antritis
RU94025702A (en) Method for treating chronic venous insufficiency of lower extremity in patients suffering from osteoarthrosis
UA30749A (en) Method of complex stimulus therapy of the severe forms of language disorders
Martin Light relief
CN1511559A (en) Powder for removing necrotic tissue and tissue regeneration

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication